Brief: Allurion Announces Plans To Combine Glp-1 Therapy With The Allurion Balloon To Treat Obesity
18/02/2025 14:17
Feb 18 (Reuters) - Allurion Technologies Inc ALUR.N :
* ALLURION ANNOUNCES PLANS TO COMBINE GLP-1 THERAPY WITH THE
ALLURION BALLOON TO TREAT OBESITY
Source text: ID:nBwc0J6cFa
Further company coverage: ALUR.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allurion Technologies
See all newsBrief: Allurion Technologies Inc - Sees Growing Demand From Patients Discontinuing Glp-1 Therapy
Brief: Allurion Intends To Appeal NYSE Notice Of Delisting, Execute Plan To Regain Compliance, And Expects To Continue Trading On NYSE
Brief: NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc.
Allurion rises on plan to offer discounted weight-loss drug Mounjaro in Argentina
Allurion rises after strong weight-loss data from combination therapy